Cargando…

Predictors of Acute and Late Toxicity in Patients Receiving Chemoradiation for Unresectable Pancreatic Cancer

PURPOSE: Patients with pancreatic cancer undergoing chemoradiation therapy may experience acute and chronic side effects. We conducted an exploratory analysis of patients with locally advanced pancreatic cancer (LAPC) undergoing definitive chemoradiation to identify factors influencing the occurrenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Das, Rishi, Abbott, Madeline R., Hadley, Scott W., Sahai, Vaibhav, Bednar, Filip, Evans, Joseph R., Schipper, Matthew J., Lawrence, Theodore S., Cuneo, Kyle C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Scientific Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692286/ https://www.ncbi.nlm.nih.gov/pubmed/38047228 http://dx.doi.org/10.1016/j.adro.2023.101266

Ejemplares similares

Gadoxetic Acid Uptake Rate as a Measure of Global and Regional Liver Function as Compared With Indocyanine Green Retention, Albumin-Bilirubin Score, and Portal Venous Perfusion
por: Simeth, Josiah, et al.
Publicado: (2022)

Predictors of Acute Hematologic Toxicity in Women Receiving Extended-Field Chemoradiation for Cervical Cancer: Do Known Pelvic Radiation Bone Marrow Constraints Apply?
por: Hara, Jared H.L., et al.
Publicado: (2022)

Prognostic Value of Early Fluorodeoxyglucose-Positron Emission Tomography Response Imaging and Peripheral Immunologic Biomarkers: Substudy of a Phase II Trial of Risk-Adaptive Chemoradiation for Unresectable Non-Small Cell Lung Cancer
por: Bowen, Stephen R., et al.
Publicado: (2021)

Chemoradiation in Unresectable Oral Cavity Cancer: A Myth or Reality!
por: Patil, Vijay Maruti, et al.
Publicado: (2020)

Treatment Discontinuation in Patients With Muscle-Invasive Bladder Cancer Undergoing Chemoradiation
por: Kotha, Nikhil V., et al.
Publicado: (2021)

Role of concurrent chemoradiation on locally advanced unresectable adenoid cystic carcinoma
por: Ha, Hyerim, et al.
Publicado: (2021)

Stenting in Palliation of Unresectable Esophageal Cancer
por: Włodarczyk, Janusz R, et al.
Publicado: (2018)

A Pilot Study of Diffusion-Weighted MRI in Patients Undergoing Neoadjuvant Chemoradiation for Pancreatic Cancer
por: Cuneo, Kyle C., et al.
Publicado: (2014)

Genomic Analyses for Predictors of Response to Chemoradiation in Stage III Non-Small Cell Lung Cancer
por: Luo, Leo Y., et al.
Publicado: (2020)

Hypofractionated Radiation Therapy for Unresectable or Metastatic Sarcoma Lesions
por: Boyce-Fappiano, David, et al.
Publicado: (2022)

Lymphopenia and Radiation Dose to Circulating Lymphocytes With Neoadjuvant Chemoradiation in Esophageal Squamous Cell Carcinoma
por: So, Tsz Him, et al.
Publicado: (2020)

MRI Radiomics for Prediction of Tumor Response and Downstaging in Rectal Cancer Patients after Preoperative Chemoradiation
por: Chen, Haihui, et al.
Publicado: (2020)

Influence of Caregiver Presence During Physician Office Visits on Patients Undergoing Chemoradiation Therapy for Esophageal Cancer
por: Ho, Joseph K., et al.
Publicado: (2021)

Outcomes and Tolerability of Definitive and Preoperative Chemoradiation in Elderly Patients With Esophageal Cancer: A Retrospective Institutional Review
por: Rahimy, Elham, et al.
Publicado: (2020)

Incidence and Dosimetric Predictors of Radiation-Induced Gastric Bleeding After Chemoradiation for Esophageal and Gastroesophageal Junction Cancer
por: Montovano, Margaret, et al.
Publicado: (2021)

Photobiomodulation During Chemoradiation for Head and Neck Cancer: Effect on Mucositis, Weight Loss, and Feeding Tube Dependence
por: Krc, Rebecca F., et al.
Publicado: (2023)

Chemoradiation therapy with docetaxel in elderly patients with stage II/III esophageal cancer: A phase 2 trial
por: Ohba, Akihiro, et al.
Publicado: (2016)

FANCD2 Mutation in a Patient With Early Rectal Cancer Receiving Definitive Chemoradiation
por: McDonald, Jordan, et al.
Publicado: (2021)

Concurrent Chemoradiation With or Without Durvalumab in Elderly Patients With Unresectable Stage III NSCLC: Safety and Efficacy
por: Lau, Sally C.M., et al.
Publicado: (2021)

Clinical Outcomes of Patients With Unresectable Primary Liver Cancer Treated With Yttrium-90 Radioembolization With an Escalated Dose
por: Chin, Re-I, et al.
Publicado: (2022)

Predictors of Pneumonitis in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation Followed by Consolidative Durvalumab
por: Diamond, Brett H., et al.
Publicado: (2022)

Identification of predictive factors for early relapse in patients with unresectable stage III non‐small cell lung cancer receiving consolidation durvalumab after concurrent chemoradiation therapy
por: Nam, Jung Hyun, et al.
Publicado: (2023)

Complete Response after Treatment with Neoadjuvant Chemoradiation with Prolonged Chemotherapy for Locally Advanced, Unresectable Adenocarcinoma of the Pancreas
por: Pompa, Tiffany A., et al.
Publicado: (2017)

The addition of deep hyperthermia to gemcitabine-based chemoradiation may achieve enhanced survival in unresectable locally advanced adenocarcinoma of the pancreas
por: Rogers, S.J., et al.
Publicado: (2021)

A narrative review of toxicity of chemoradiation and immunotherapy for unresectable, locally advanced non-small cell lung cancer
por: Prasad, Rahul N., et al.
Publicado: (2020)

Proton Therapy for Unresectable and Medically Inoperable Locally Advanced Pancreatic Cancer: Results From a Multi-Institutional Prospective Registry
por: Eckstein, Jacob, et al.
Publicado: (2023)

Stereotactic body radiation therapy is associated with improved overall survival compared to chemoradiation or radioembolization in the treatment of unresectable intrahepatic cholangiocarcinoma
por: Sebastian, Nikhil T., et al.
Publicado: (2019)

Video Consent: a Pilot Study of Informed Consent in Laparoscopic Urology and Its Impact on Patient Satisfaction
por: Sahai, Arun, et al.
Publicado: (2006)

Dietary Flaxseed in Non-Small Cell Lung Cancer Patients Receiving Chemoradiation
por: Berman, Abigail T, et al.
Publicado: (2013)

Late Results After Splenectomy in Adult Idiopathic Thrombocytopenic Purpura
por: Vecchio, Rosario, et al.
Publicado: (2015)

Results of a Single Institution Experience with Dose-Escalated Chemoradiation for Locally Advanced Unresectable Non-Small Cell Lung Cancer
por: Bernard, Mark E., et al.
Publicado: (2017)

Duration of chemotherapy prior to chemoradiation affects survival outcomes for resected stage I‐II or unresected stage III pancreatic cancer
por: Ma, Sung J., et al.
Publicado: (2019)

Consolidation treatment of durvalumab after chemoradiation in real‐world patients with stage III unresectable non‐small cell lung cancer
por: Chu, Chia‐Hsun, et al.
Publicado: (2020)

Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab
por: Jazieh, Khalid, et al.
Publicado: (2022)

Late Prevertebral and Spinal Abscess following Chemoradiation for Laryngeal Squamous Cell Carcinoma
por: Hindy, Jawad, et al.
Publicado: (2014)

Detection of late radiation damage on left atrial fibrosis using cardiac late gadolinium enhancement magnetic resonance imaging
por: Huang, Y. Jessica, et al.
Publicado: (2016)

Electrons receive individual treatment with electron-event representation
por: Danev, Radostin
Publicado: (2020)

It is never too late to rethink serum folate()
por: Fertrin, Kleber Yotsumoto
Publicado: (2018)

Drug-eluting Microspheres Compared to Conventional Transarterial Chemoembolization as First Line Treatment for Unresectable Hepatocellular Carcinoma: A Single-center Retrospective Cost-utility Analysis
por: Andreozzi, G., et al.
Publicado: (2023)

Practical challenges in patients with stage III NSCLC receiving checkpoint inhibitors after chemoradiation
por: Shukla, Nikhil A, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mvtjuhsk4qc3q154d5ej5v2044